News Jan 09, 2021

Traphaco is ranked No. 1 in the TOP 5 Prestigious Oriental Pharmaceutical Companies in 2020

The rankings were officially announced by Vietnam Report Joint Stock Company on November 26^th, 2020 and awarded the Certificate to the Representative of Traphaco Joint Stock Company on January 8^th, 2021.

Top 5 prestigious Vietnamese Oriental Pharmaceutical Companies in 2020:

Source: Vietnam Report, Top 5 Prestigious Oriental Pharmaceutical Companies in 2020, November 2020

Ms. Dao Thuy Ha - Marketing Director, representing Traphaco Joint Stock Company, received the Certificate

The ranking of Top 5 prestigious oriental pharmaceutical companies is built on scientific and objective principles. Companies are assessed and ranked based on 3 main criterias: (1) Financial capacity shown on the most recent financial report; (2) Media reputation is assessed by Media Coding method - encoding the company's articles on influential media channels; (3) The stakeholder survey was conducted in October and November 2020.

Besides, Traphaco JSC continued to be in the Top 10 prestigious pharmaceutical manufacturing companies for 5 consecutive years (2016-2020).

On January 6, 2021, Traphaco Joint Stock Company held a conference to summarize the year 2020 and orientations for 2021. The Board of Directors reported the results of production and business activities in 2020 with many highlights: Consolidated profit reached 203 billion , exceeding 13% of the plan (180 billion), increasing by 19% compared to 2019; Breakthrough with new products, deploying 19 products to the market on schedule, contributing 55 billion dong in revenue; Average income in 2020 increased 20% over the same period, reaching over 20 million VND / person / month. The Board of Directors acknowledged the efforts of the all leaders and employees of the company promptly and flexibly converted to adapt to the difficult situation caused by epidemics and natural disasters, creating good growth. In 2021, the Board of Directors temporarily assigns the main targets: Consolidated revenue: 2,100 billion VND; Consolidated profit after tax: VND 230 billion.